UK markets open in 7 hours 58 minutes
NIKKEI 225
38,617.10 -329.83 (-0.85%) HANG SENG
19,195.60 -25.02 (-0.13%) CRUDE OIL
77.13 -0.44 (-0.57%) GOLD FUTURES
2,382.40 -10.50 (-0.44%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,305.76 -875.04 (-1.59%)
Thermo Fisher Scientific Inc. (TN8.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 207.42B |
| Enterprise value | 233.53B |
| Trailing P/E | 37.88 |
| Forward P/E | 27.40 |
| PEG ratio (5-yr expected) | 2.38 |
| Price/sales (ttm) | 5.38 |
| Price/book (mrq) | 4.95 |
| Enterprise value/revenue | 5.97 |
| Enterprise value/EBITDA | 22.35 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.80 |
| 52-week change 3 | 15.38% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 559.30 |
| 52-week low 3 | 397.00 |
| 50-day moving average 3 | 535.53 |
| 200-day moving average 3 | 493.52 |
Share statistics
| Avg vol (3-month) 3 | 184 |
| Avg vol (10-day) 3 | 129 |
| Shares outstanding 5 | 381.72M |
| Implied shares outstanding 6 | 381.77M |
| Float 8 | 380.82M |
| % held by insiders 1 | 0.18% |
| % held by institutions 1 | 90.80% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.47 |
| Forward annual dividend yield 4 | 0.27% |
| Trailing annual dividend rate 3 | 1.44 |
| Trailing annual dividend yield 3 | 0.26% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 9.24% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 14 Mar 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 30 Mar 2024 |
Profitability
| Profit margin | 14.20% |
| Operating margin (ttm) | 16.67% |
Management effectiveness
| Return on assets (ttm) | 4.82% |
| Return on equity (ttm) | 13.62% |
Income statement
| Revenue (ttm) | 42.49B |
| Revenue per share (ttm) | 110.37 |
| Quarterly revenue growth (yoy) | -3.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 10.78B |
| Net income avi to common (ttm) | 6.03B |
| Diluted EPS (ttm) | 14.36 |
| Quarterly earnings growth (yoy) | 3.00% |
Balance sheet
| Total cash (mrq) | 7.25B |
| Total cash per share (mrq) | 18.99 |
| Total debt (mrq) | 35.66B |
| Total debt/equity (mrq) | 78.17% |
| Current ratio (mrq) | 1.70 |
| Book value per share (mrq) | 119.24 |
Cash flow statement
| Operating cash flow (ttm) | 8.93B |
| Levered free cash flow (ttm) | 6.07B |
© 2024 Yahoo. All rights reserved.